One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
The Decision to Replace Fed Chair Jerome Powell Is in Final Stretch
-
Trump wants a loyalist. Senators want independence. Backlash in progress.
4 hours ago
No comments:
Post a Comment